Today: 29 April 2026
UOB share price stalls near S$39 as traders brace for Feb. 24 results
5 February 2026
1 min read

UOB share price stalls near S$39 as traders brace for Feb. 24 results

Singapore, Feb 5, 2026, 15:01 SGT — Regular session

  • UOB shares saw little movement in afternoon trading following a subdued week to date
  • Investors are making moves ahead of UOB’s full-year results, due Feb. 24
  • Broker calls are still divided following the wave of downgrades and upgrades in January

Shares of United Overseas Bank (UOB) held steady on Thursday, as traders hesitated to drive the stock higher following a strong January rally that pushed it to record highs.

The stock slipped 0.03% to S$38.58 by mid-afternoon, bouncing between S$38.45 and S$38.72 earlier. Volume hovered around 1.1 million shares, per data.

This is crucial with UOB’s key date looming in under three weeks. The bank’s results usually reset expectations for dividends, buybacks, and loan-loss buffers across Singapore’s banks.

The stock remains near recent highs. In such a tight trading range, even minor tweaks in guidance can have a big impact.

UOB announced in an SGX filing that it will publish its full-year 2025 financial results on Feb. 24, ahead of market open.

Investors are zeroing in on two key factors: net interest margin—the gap between what banks earn from loans versus what they pay on deposits—and the provisions banks must set aside for potential loan losses.

Broker opinions are split. JPMorgan cut UOB to “underweight” late last month, sticking with a S$34 target price. On the flip side, Macquarie bumped its rating to “outperform” and set a S$41 target, The Business Times reported.

UOB has flagged the risk of margin pressure ahead. Back in November, the bank flagged its 2026 net interest margin would likely fall short of 2025’s forecast, following a third-quarter profit drop driven by a spike in credit provisions, Reuters reported.

The broader market edged lower on Thursday. Singapore shares dipped as investors digested corporate updates, including the latest earnings from Singapore Exchange, The Straits Times reported.

Risks remain two-sided. Should margins shrink faster than expected or credit costs hold firm, bank shares could reverse sharply — particularly following recent gains.

UOB will release its full-year results on Feb. 24, ahead of the market open. Investors will be watching closely for updates on margin forecasts, credit conditions, and the 2026 shareholder return strategy.

Stock Market Today

  • Blockworks aims to be the Morningstar of crypto with new fundraising and acquisitions
    April 29, 2026, 10:14 AM EDT. Blockworks, a crypto startup, plans to dominate as a data provider for cryptocurrency and tokenized assets. The company secured a Series A round extension led by ParaFi Capital and Reciprocal Ventures, valuing it at $192 million, and intends to acquire rivals to expand its platform. Co-founder Jason Yanowitz highlighted a trust gap in crypto, with insufficient institutional-grade data and research compared to traditional finance tools like Morningstar and Moody's. Blockworks' annual recurring revenue surged over 500% last year, fueled partly by its Digital Assets Summit. The firm wants to unify fragmented crypto data services, improving trader access to reliable information and potentially accelerating digital asset adoption.

Latest article

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

Lemonade Stock Jumps as Q1 Revenue Surge Sharpens Its 2026 Profit Test

29 April 2026
Lemonade Inc reported first-quarter revenue of $258 million, up 71% from a year earlier, and narrowed its net loss to $35.8 million, or 47 cents a share. Shares rose 5.6% in premarket trading after results beat estimates. In-force premium climbed 32% to $1.33 billion, with customers up 23% to 3.14 million. The company raised its 2026 outlook and now expects full-year revenue of up to $1.203 billion.
Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
PLS Group share price slides 3.7% as big-holder filings stack up and exec loan-share plan hits the register
Previous Story

PLS Group share price slides 3.7% as big-holder filings stack up and exec loan-share plan hits the register

Woodside Energy share price today: WDS closes higher as oil slips ahead of US-Iran talks
Next Story

Woodside Energy share price today: WDS closes higher as oil slips ahead of US-Iran talks

Go toTop